Document is current
Any future updates will be listed below
-
Authors
Zierhut, Marco
Hahne, Inge
Bergmann, Niklas
Grässer, Sofie
Alt, Max
Töbelmann, Laura
Wohlthan, Josefa
Huber, Viktoria
Ta, Thi Minh Tam
Bajbouj, Malek
Hahn, Eric
Böge, Kerem
-
Funding
Funding for this research was provided by:
Charité - Universitätsmedizin Berlin
- License Information
-
More Information
Article History
Received: 9 September 2025
Accepted: 2 March 2026
First Online: 12 March 2026
Declarations
:
: The authors assert that all procedures contributing to this work comply with the ethical standards of the relevant national and institutional committees on human experimentation and with the Helsinki Declaration of 1975, as revised in 2008. All procedures involving human subjects/patients were approved by the ethical committee of the Charité – Universitätsmedizin Berlin (EA4/196/19). Written informed consent to participate was obtained from all participants prior to their inclusion in the study.
: Written informed consent to publish the data was obtained from all participants prior to their inclusion in the study.
: Marco Zierhut reports a relationship with Boehringer Ingelheim Pharma GmbH & Co KG that includes: consulting or advisory and speaking and lecture fees. Kerem Boege reports a relationship withBoehringer Ingelheim Pharma GmbH & Co KG that includes: consulting or advisory and speaking andlecture fees. Other authors declare that they have no known competing financialinterests or personal relationships that could have appeared to influence the work reported in thispaper.
